Acne, depression, and suicide

Dermatologic Clinics

Volumn 23, Issue 4 SPEC. ISS., 2005, Pages 665-674

  Hull, Peter R ^a   D'Arcy, Carl ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEXAROTENE; ETRETIN; ETRETINATE; ISOTRETINOIN; MINOCYCLINE; RETINOIC ACID RECEPTOR; RETINOID; RETINOL;

ACNE; AGGRESSION; ANGER; ANXIETY; BODY IMAGE; CHILD BEHAVIOR; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG MECHANISM; EMOTIONAL STRESS; FATIGUE; HUMAN; MAJOR DEPRESSION; MEDLINE; MELANCHOLIA; MENTAL HEALTH; MOOD DISORDER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL WITHDRAWAL; QUESTIONNAIRE; REVIEW; SELF ESTEEM; SIDE EFFECT; SOCIAL STATUS; SOMNOLENCE; SUICIDAL BEHAVIOR; SUICIDE; UNITED STATES;

EID: 23844539331     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2005.05.008     Document Type: Review

References (83)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders-IV 4th edition 1994 American Psychiatric Association Washington, DC
2. S.B. Patten Incidence of major depression in Canada CMAJ 163 2000 714 715
3. Statistics Canada Canadian Community Health Survey of Mental Health and Well-Being Available at: http://www.statcan.ca/English/freepub/82-617-XIE Accessed June 21, 2005
4. R.C. Kessler, P. Berglund, and O. Demler Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psych 62 2005 593 602
5. N. Singleton, R. Bumpstead, M. O'Brien for the Office of National Statistics Psychiatric morbidity among adults living in private households, 2000 2001 Her Majesty's Stationery Office London
6. Commonwealth Department of Health and Aged Care and Australian Institute of Health and Welfare National health priority areas report: mental health 1998 [cat. no. PHE13] 1999 Health and AIHW Canberra (Australia)
7. Based on the authors' analysis of the data in the public use data file for the Canadian Community Health Survey of Mental Health and Well-being. Available upon application submission to Statistics Canada
8. J.M. Rey, M.G. Sawyer, and J.J. Clark Depression among Australian adolescents Med J Aust 175 2001 19 23
9. R.C. Kessler, K.A. McGonagle, and S. Zhao Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8 19
10. National Institutes of Health US Department of Health and Human Services National Institute for Mental Health Depression in children and adolescents: a fact sheet for physicians Available at: http://www.nimh.nih.gov/publicat/ NIMHdepchildresfact.pdf Accessed January 30, 2004
11. H.C. Wilcox, and J.C. Anthony Child and adolescent clinical features as forerunners of adult-onset major depressive disorder: retrospective evidence from an epidemiological sample J Affect Disord 82 2004 9 20
12. P. Wu, C.W. Hoven, and X. Liu Substance use, suicidal ideation and attempts in children and adolescents Suicide Life Threat Behav 34 2004 408 420
13. D.M. Adams, and J.C. Overholser Suicidal behavior and history of substance abuse Am J Drug Alcohol Abuse 18 1992 343 354
14. P.A. Rutter, and A.E. Behrendt Adolescent suicide risk: four psychosocial factors Adolescence 39 2004 295 302
15. Statistics Canada Suicides and suicide rate, by sex and by age group Available at: http://www.statcan.ca/english/Pgdb/health01.htm Accessed January 30, 2005
16. S. Shuster, G.H. Fisher, and E. Harris The effect of skin disease on self image [proceedings] Br J Dermatol 99 Suppl 16 1978 18 19
17. J. Koo The psychosocial impact of acne: patients' perceptions J Am Acad Dermatol 32 1995 S26 S30
18. J.K. Tan Psychosocial impact of acne vulgaris: evaluating the evidence Skin Therapy Lett 9 2004 1 9
19. S.C. Kellett, and D.J. Gawkrodger The psychological and emotional impact of acne and the effect of treatment with isotretinoin Br J Dermatol 140 1999 273 282
20. M.A. Gupta, and A.K. Gupta Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis Br J Dermatol 139 1998 846 850
21. A.F. Klassen, J.N. Newton, and E. Mallon Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures J Am Acad Dermatol 43 2 Pt 1 2000 229 233
22. E. Mallon, J.N. Newton, and A. Klassen The quality of life in acne: a comparison with general medical conditions using generic questionnaires Br J Dermatol 140 1999 672 676
23. K. Yazici, K. Baz, and A.E. Yazici Disease-specific quality of life is associated with anxiety and depression in patients with acne J Eur Acad Dermatol Venereol 18 2004 435 439
24. S. Aktan, E. Ozmen, and B. Sanli Anxiety, depression, and nature of acne vulgaris in adolescents Int J Dermatol 39 2000 354 357
25. K.J. Rothman Causes Am J Epidemiol 104 1976 587 592
26. S.B. Patten, and C. Barbui Drug-induced depression: a systematic review to inform clinical practice Psychother Psychosom 73 2004 207 215
27. D.K. Wysowski, M. Pitts, and J. Beitz An analysis of reports of depression and suicide in patients treated with isotretinoin J Am Acad Dermatol 45 2001 515 519
28. K.J. Rothman, and S. Greenland Causation and causal inference R.J. Rothman S. Greenland Modern epidemiology 1998 Lippincott-Raven Philadelphia 7 28
29. J.D. Bremner Does isotretinoin cause depression and suicide? Psychopharmacol Bull 37 2003 64 78
30. S.J. Enders, and J.M. Enders Isotretinoin and psychiatric illness in adolescents and young adults Ann Pharmacother 37 2003 1124 1127
31. P.R. Hull, and C. D'Arcy Isotretinoin use and subsequent depression and suicide: presenting the evidence Am J Clin Dermatol 4 2003 493 505
32. D.G. Jacobs, N.L. Deutsch, and M. Brewer Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 45 2001 S168 S175
33. C.H. Ng, and I. Schweitzer The association between depression and isotretinoin use in acne Aust N Z J Psychiatry 37 2003 78 84
34. J. O'Donnell Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide Am J Ther 10 2003 148 159
35. J.A. Cotterill Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image Br J Dermatol 104 1981 611 619
36. P.G. Hazen, J.F. Carney, and A.E. Walker Depression: a side effect of 13-cis-retinoic acid therapy J Am Acad Dermatol 9 1983 278 279
37. H. Lindemayr Isotretinoin intoxication in attempted suicide Acta Derm Venereol 66 1986 452 453
38. J.M. Burket, and F.J. Storrs Nodulocystic infantile acne occurring in a kindred of steatocystoma Arch Dermatol 123 1987 432 433
39. P.L. Scheinman, G.L. Peck, and D.R. Rubinow Acute depression from isotretinoin J Am Acad Dermatol 22 1990 1112 1114
40. N.C. Hepburn Deliberate self-poisoning with isotretinoin Br J Dermatol 122 1990 840 841
41. S. Gatti, and F. Serri Acute depression from isotretinoin [letter] J Am Acad Dermatol 25 1991 132
42. E.E. Duke, and L. Guenther Psychiatric reactions to the retinoids Canadian Journal of Dermatology 5 1992 467
43. P. Bravard, and M. Krug RJC. Isotretinoin and depression: care is needed [letter] Nouv Dermatol 12 1993 215
44. A. Byrne, and G. Hnatko Depression associated with isotretinoin therapy Can J Psychiatry 40 1995 567
45. S. Aubin, G. Lorette, and C. Muller Massive isotretinoin intoxication Clin Exp Dermatol 20 1995 348 350
46. P.R. Hull, and C. Demkiw-Bartel Isotretinoin use in acne: prospective evaluation of adverse events J Cutan Med Surg 4 2000 66 70
47. O. Robusto Depression caused by an anti-acne agent Acta Med Port 15 2002 325 326
48. F. van Broekhoven, R.J. Verkes, and J.G. Janzing Psychiatric symptoms during isotretinoin therapy Ned Tijdschr Geneeskd 147 2003 2341 2343
49. L.G. Millard Adverse mood and behaviour change in young patients on systemic isotretinoin Br J Dermatol 141 Suppl 55 1999 16
50. C.H. Ng, M.M. Tam, and S.J. Hook Acne, isotretinoin treatment and acute depression World J Biol Psychiatry 2 2001 159 161
51. G.M. Shehi, and W.J. Bryson Hypersomnia associated with isotretinoin in a patient with recurrent major depressive disorder and acne vulgaris Sleep 27 2004 821
52. Y. Barak, Y. Wohl, and Y. Greenberg Affective psychosis following Accutane (isotretinoin) treatment Int Clin Psychopharmacol 20 2005 39 41
53. C.M. Wray Accutane and depression Canadian Adverse Drug Reaction Newsletter 9 1999 1 Available at: http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/ adrv9n1_e.html Accessed January 31, 2005
54. Depression with isotretinoin Australian Adverse Drug Reactions Bulletin 17 1998 3 Available at: http://www.tga.gov.au/docs/html/aadrbltn/aadr9808. htm#isot Accessed January 30, 2005
55. Irish Medicines Board Roaccutane Drug Safety Newsletter 7th Edition 1998 Available at: http://www.imb.ie/uploads/publications/7077996_Issue%208.pdf Accessed January 30, 2005
56. The Danish Medicines Agency Psychic adverse reactions to the use of the acne medicine isotretinoin (trade name Roaccutan, Accutin, Isotretinoin, Isotrex). Danish Medicines Agency Available at: http://www.dkma.dk/1024/ visUKLSArtikel.asp?artikelID=2302 Accessed January 30, 2005
57. Lammy House of Commons Hansard Written Answers for 27th January 2003 Available at: http://www.publications.parliament.uk/cgi-bin/ukparl_hl?DB= ukparl&STEMMER=en&WORDS=isotretinoin+&COLOUR=Red&STYLE= s&URL=/pa/cm200203/cmhansrd/vo030127/text/30127w46.htm#30127w46.html_spnew0 Accessed January 30, 2005
58. C.H. Ng, M.M. Tam, and E. Celi Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy Australas J Dermatol 43 2002 262 268
59. S.S. Jick, H.M. Kremers, and C. Vasilakis-Scaramozza Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide Arch Dermatol 136 2000 1231 1236
60. D.K. Wysowski Methodological limitations of the study "isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide [letter] Arch Dermatol 137 2001 1102
61. K. Hersom, M.P. Neary, and H.P. Levaux Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis J Am Acad Dermatol 49 2003 424 432
62. P.M. Lewinsohn, P. Rohde, and J.R. Seeley Treatment of adolescent depression: frequency of services and impact on functioning in young adulthood Depress Anxiety 7 1998 47 52
63. M. Kovacs, T.L. Feinberg, and M. Crouse-Novak Depressive disorders in childhood. II. A longitudinal study of the risk for a subsequent major depression Arch Gen Psychiatry 41 1984 643 649
64. M.B. Keller, P.W. Lavori, and W.R. Beardslee Depression in children and adolescents: new data on undertreatment and a literature review on the efficacy of available treatments J Affect Disord 21 1991 163 171
65. M.P. Neary, W. Klaskala, and J. McLane Epidemiological study of adverse events in Accutane users and matched non-users: retrospective analysis of major US health plan claims database [abstract] Pharmacoepidemiol Drug Saf 10 Suppl 1 2001 S141
66. A. Bendich, and L. Langseth Safety of vitamin A Am J Clin Nutr 49 1989 358 371
67. R.M. Restak Pseudotumor cerebri, psychosis, and hypervitaminosis A J Nerv Ment Dis 155 1972 72 75
68. E.F. McCance-Katz, and L.H. Price Depression associated with vitamin A intoxication Psychosomatics 33 1992 117 118
69. G. Stuttgen Oral vitamin A acid therapy Acta Derm Venereol Suppl (Stockh) 74 1975 174 179
70. C.A. Henderson, and A.S. Highet Depression induced by etretinate [letter] BMJ 298 1989 964
71. M.J.M. Borbujo, J.M. Casado, and L.M.B. Garijo An unusual secondary effect of etretinate Med Clin (Barc) 89 1987 577
72. J. Mey, and P. McCaffery Retinoic acid signaling in the nervous system of adult vertebrates Neuroscientist 10 2004 409 421
73. S. Campbell, and G. Macqueen The role of the hippocampus in the pathophysiology of major depression J Psychiatry Neurosci 29 2004 417 426
74. Y.I. Sheline, B.L. Mittler, and M.A. Mintun The hippocampus and depression Eur Psychiatry 17 Suppl 3 2002 300 305
75. Y.I. Sheline Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity? Mol Psychiatry 1 1996 298 299
76. Y.I. Sheline, P.W. Wang, and M.H. Gado Hippocampal atrophy in recurrent major depression Proc Natl Acad Sci U S A 93 1996 3908 3913
77. Y.I. Sheline, M.H. Gado, and H.C. Kraemer Untreated depression and hippocampal volume loss Am J Psychiatry 160 2003 1516 1518
78. Y. Sakai, J.E. Crandall, and J. Brodsky 13-cis Retinoic acid (Accutane) suppresses hippocampal cell survival in mice Ann N Y Acad Sci 1021 2004 436 440
79. J.D. Bremner, N. Fani, and N. Ashraf Functional brain imaging alterations in acne patients treated with isotretinoin [abstract]. Program No. 114.2. 2004 Abstract Viewer/Itinerary Planner 2004 Society for Neuroscience Washington
80. K. McCoy Drugmaker rebuffed call to monitor users. December 12, 2004 Available at: http://www.usatoday.com/money/industries/health/drugs/2004-12-06- accutanecover_x.htm Accessed June 21, 2005
81. World Health Organization Available at: http://who.int/mental_health/ prevention/suicide/country_reports/en/index.html Accessed June 22, 2005
82. US Food and Drug Administration Dermatologic and Ophthalmic Advisory Committee. Hoffmann-La Roche. Briefing information. September 2000 Available at: http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3639b1c_05.pdf Accessed June 22, 2005
83. Statistics Canada. Depression. In: Health indicators, May 2002 [cat. no. 82-221-XIE]. Available at: http://www.statcan.ca:80/english/freepub/82-221-XIE/ 00502/hlthstatus/conditions2.htm#depression. Accessed June 22, 2005